TORONTO, Jan. 29 /CNW/ - MDS Inc. (TSX: MDS; NYSE: MDZ), a leading
provider of products and services to the global life sciences markets, today
filed the Company's Annual Report, Annual Information Form, Annual Proxy
Circular and its 2008 Management Discussion and Analysis (MD&A) with financial
statements and notes for the fiscal year ended October 31, 2008.
These documents, which are available on the Company's Website at
www.mdsinc.com, have also been filed with the relevant security regulators.
They can be accessed on the EDGAR section of the U.S. Securities and Exchange
Commission's Website at www.sec.gov, and will be available on the Canadian
Securities Administrators Website at www.sedar.com.
Upon request, hard copies of the Company's audited financial statements
will be provided free of charge to security holders. They can be obtained by
completing a Report Request form, which is available on MDSInc.com at
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that
provides market-leading products and services that our customers need for the
development of drugs, and the diagnosis and treatment of disease. We are a
leading global provider of pharmaceutical contract research, medical isotopes
for molecular imaging, radiotherapeutics, and analytical instruments. MDS has
more than 5,000 highly skilled people in 29 countries. Find out more at
www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
For further information:
For further information: MEDIA: Paul Stulberg, (416) 675-6777, ext.
32265, firstname.lastname@example.org; INVESTORS: Kim Lee, (416) 213-4721,